M&A Deal Summary

Odyssey Investment Partners Acquires TrialCard

On November 14, 2017, private equity firm Odyssey Investment Partners acquired healthcare services company TrialCard from Excellere Partners

Acquisition Highlights
  • This is Odyssey Investment Partners’ 2nd transaction in the Healthcare Services sector.
  • This is Odyssey Investment Partners’ 38th transaction in the United States.
  • This is Odyssey Investment Partners’ 3rd transaction in North Carolina.

M&A Deal Summary
Date 2017-11-14
Target TrialCard
Sector Healthcare Services
Buyer(s) Odyssey Investment Partners
Sellers(s) Excellere Partners
Deal Type Secondary Buyout

Target

TrialCard

Morrisville, North Carolina, United States
website
TrialCard is a provider of patient access and medication adherence support services on behalf of pharmaceutical manufacturers. TrialCard was founded in 2001 and is based in Morrisville, North Carolina.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Odyssey Investment Partners

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1997
PE ASSETS 8.2B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Odyssey Investments is a private equity firm that seeks control/majority investments in middle-market companies. Odyssey looks to back existing management and make investments in the form of leveraged acquisitions, growth financings and recapitalizations. Sectors of interest include industrial manufacturing, business and financial services, aerospace products and services, and 'route-based services'. Odyssey Investment Partners is based in New York City with an additional office in Woodland Hills, California.

DEAL STATS #
Overall 41 of 52
Sector (Healthcare Services) 2 of 3
Type (Secondary Buyout) 15 of 23
State (North Carolina) 3 of 4
Country (United States) 38 of 49
Year (2017) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-05 CPI

Santa Rosa, California, United States

CPI is a direct marketer, designer and manufacturer of innovative OEM and end-user solutions in analytical science and technology. The company manufactures a range of technical analytical instrument components, high-purity standard solutions and reagents and other analytical testing products for the environmental, petrochemical, pharmaceutical, biotechnology and semiconductor industries. CPI’s worldwide customers include IBM, Intel, Pfizer, Merck, Bayer, US Filter, Safety Kleen, Chevron, Ashland Chemical, Dupont and BASF as well as numerous federal, state, academic and private laboratories. Direct sales and marketing are conducted worldwide, from offices in the United States, Canada, Europe and Japan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-04 EAG Laboratories

San Diego, California, United States

EAG Laboratories is a North American provider of advanced chemical testing services for pesticides, industrial and household chemicals. It provides end-to-end support for e-fate, metabolism, eco-toxicology and residue studies required for pesticide and chemical regulatory testing to support global registration requirements.

Sell $780M

Seller(S) 1

SELLER

Excellere Partners

Denver, Colorado, United States

website

Category Private Equity Firm
Founded 2006
PE ASSETS 2.3B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Excellere Partners is a private equity firm focused on mid-market recapitalizations, management buyouts, and consolidation opportunities. Excellere looks to partner with management on transactions and targets opportunities in business services, education/training, healthcare, industrial services, and specialty foods. Excellere Partners was formed in 2006 and is based in Denver, Colorado.

DEAL STATS #
Overall 8 of 11
Sector (Healthcare Services) 5 of 5
Type (Secondary Buyout) 5 of 6
State (North Carolina) 1 of 1
Country (United States) 8 of 11
Year (2017) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-25 Biocare Medical

Pacheco, California, United States

Biocare Medical is a provider of immunohistochemistry (IHC) instrumentation, as well as a full range of reagents for IHC and molecular testing. The company engages in IHC and molecular diagnostic reagents, including simultaneous Multiplex IHC tests that provide increased confidence at critical diagnostic decision points, positively influencing patient therapy while accelerating turnaround time. Biocare Medical was formed in 1997 and is based in Pacheco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-30 Concord Technologies

Seattle, Washington, United States

Concord Technologies is a provider of secure, cloud-based interoperability and automation technology for healthcare and other document-intensive industries. Serving over 1,500 customers, Concord’s solutions help transfer, process, and integrate unstructured data within customers’ existing systems and operational processes. Concord Technologies was founded in 1996 and is based in Seattle, Washington.

Buy -
Mergr

Product

Company

Legal